Education
About Us
Working with TipRanks
Follow Us
Vericel Corporation (VCEL)
NASDAQ:VCEL
Earnings Data
Report Date
May 13, 2026TBA (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
-0.15Last Year’s EPS
-0.23Same Quarter Last Year
Strong Buy
Based on 6 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call presented a strongly positive operational and financial picture: record Q4 and full-year revenue, robust MACI momentum, substantial margin expansion, a strong cash position, successful sales‑force expansion, and advancement of clinical and manufacturing initiatives. Management provided constructive but conservative 2026 guidance that leaves room for upside from rep productivity, MACI Arthro adoption, and a potential BARDA award. Key risks include near-term margin compression (Q1), execution and ramp timing for the expanded sales force, reliance in part on pricing, and uncertainty around BARDA/NexoBrid timing. Taken together, the positive achievements (record growth, high margins, cash, product and clinical progress) noticeably outweigh the manageable near-term headwinds and uncertainties.Company Guidance
Record Quarterly and Annual Revenue
Q4 2025 total revenue of $92.9M, up 23% year-over-year; full year 2025 total revenue of $276.3M, above the high end of guidance.
MACI Franchise Momentum
MACI Q4 revenue of $84.1M, up 23% year-over-year and +51% sequential vs. Q3; full year MACI revenue $239.5M, up 21% YoY; MACI has delivered ~24% CAGR over 9 years and 20%+ growth in each of the last 3 years; over 20,000 patients treated to date.
Strong Profitability and Margin Expansion
Q4 gross profit >$73M representing ~79% gross margin and adjusted EBITDA >$37M (40% margin) — highest quarterly margins to date; full year gross margin 74% (up ~200 bps YoY) and adjusted EBITDA margin 26% (up >300 bps YoY).
Solid Cash Position and Cash Generation
Ended 2025 with approximately $200M in cash and investments (increase of $35M in H2) and generated $52M of operating cash flow for the full year; no debt.
Commercial Expansion: Sales Force and MACI Arthro Training
Completed MACI sales force expansion (≈30% territory expansion, ~30 new reps) and trained ~1,000 surgeons on MACI Arthro; MACI Arthro-trained and implanting surgeons show higher biopsy and implant growth and higher conversion rates.
Clinical and Product Development Progress
Initiated Phase III MACI Ankle (MASCOT) clinical study in Q4 2025; on track to begin commercial manufacturing at new Burlington facility in 2026 and pursuing staged OUS expansion with planned MHRA submission mid-2026 and potential U.K. launch in 2027.
Clear 2026 Financial Guidance with Upside Potential
2026 guidance: total revenue $316M–$326M; MACI $280M–$286M; Burn Care ~$36M–$40M; full year gross margin ~75% and adjusted EBITDA margin ~27%; Q1 MACI guide $54M–$55M and Burn Care $9M–$10M with expected >20% company revenue growth in Q1.
Burn Care Performance and Cross-Selling
Burn Care Q4 revenue $8.8M (above guidance); full year Burn Care revenue $36.8M (Epicel $32.1M, NexoBrid $4.7M); Burn Care team consolidated (17 territories) cross-selling both products, with NexoBrid orders from >70 of ~90 target accounts.
VCEL Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
VCEL Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Feb 26, 2026 | $37.09 | $37.68 | +1.59% |
Nov 06, 2025 | $37.20 | $38.75 | +4.17% |
Jul 31, 2025 | $40.66 | $34.94 | -14.07% |
May 08, 2025 | $40.47 | $41.87 | +3.46% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Vericel Corporation (VCEL) report earnings?
Vericel Corporation (VCEL) is schdueled to report earning on May 13, 2026, TBA (Confirmed).
What is Vericel Corporation (VCEL) earnings time?
Vericel Corporation (VCEL) earnings time is at May 13, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is VCEL EPS forecast?
VCEL EPS forecast for the fiscal quarter 2026 (Q1) is -0.15.